Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

76.47USD
4:00pm EDT
Price Change (% chg)

$-0.18 (-0.23%)
Prev Close
$76.65
Open
$76.50
Day's High
$76.73
Day's Low
$76.20
Volume
430,723
Avg. Vol
615,328
52-wk High
$77.30
52-wk Low
$62.80

BAX.N

Chart for BAX.N

About

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.... (more)

Overall

Beta: 0.72
Market Cap (Mil.): $41,590.28
Shares Outstanding (Mil.): 542.60
Dividend: 0.52
Yield (%): 2.71

Financials

  BAX.N Industry Sector
P/E (TTM): 21.58 31.20 36.09
EPS (TTM): 3.55 -- --
ROI: -- 9.64 18.19
ROE: -- 11.31 19.06
Search Stocks

Gambro acquisition boosts Baxter's sales

- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB [EQTPRM.UL] last year.

17 Jul 2014

UPDATE 2-Gambro acquisition boosts Baxter's sales

July 17 - Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

17 Jul 2014

CORRECTED-UPDATE 1-Medical products boost Baxter's sales

(Corrects year-earlier net adjusted income figure in paragraph 2 to $659 million from $639 million. Also corrects year-ago per-share figure to $1.20 from $1.16)

17 Jul 2014

CORRECTED-Baxter earnings, sales beat estimates

(Corrects year-earlier net adjusted income figure in paragraph 2 to $659 million from $639 million. Also corrects year-ago per-share figure to $1.20 from $1.16)

17 Jul 2014

UPDATE 1-Medtronic's Covidien deal raises bar for rivals to merge

(Rewrites with analyst, fund manager comment on potential future deals)

16 Jun 2014

U.S. justices decline to hear dialysis machine patent case

WASHINGTON - The U.S. Supreme Court declined on Monday to hear an appeal filed by healthcare company Baxter International Inc over a patent dispute with rival Fresenius Medical Care AG & Co.

19 May 2014

U.S. justices decline to hear dialysis machine patent case

WASHINGTON, May 19 - The U.S. Supreme Court declined on Monday to hear an appeal filed by healthcare company Baxter International Inc over a patent dispute with rival Fresenius Medical Care AG & Co.

19 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 06,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

06 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 05,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

05 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 02,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

02 May 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.11 0.00
Pfizer Inc. (PFE.N) $30.10 -0.09
Roche Holding Ltd. (ROG.VX) CHF265.50 -1.50
Abbott Laboratories (ABT.N) $42.93 -0.11
Boston Scientific Corporation (BSX.N) $12.97 -0.14
Wyeth Limited (WLED.NS) Rs939.80 +12.90
Hospira, Inc. (HSP.N) $51.84 +0.12

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks